Drugmakers Limit Cancer Patient Access to Financial Lifeline

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

Several major drugmakers have restricted commercially insured patients from their patient assistance programs, leaving patients uncertain about how they’ll be able to afford their medications.
Medscape Medical News